Kidney stones and gout: Sodium-Glucose Cotransporter 2 Inhibitors help
PREMIUM CONTENT subscriber access
My past newsletter discussed ways to improve renal function and overall health.
Key kidney care leading to longevity
My recent newsletters featured water, ion and amino acid transporters which brought to mind that master organ for such, our kidneys. They deserve to be featured and voila, here is their newsletter.
Kidney stone formation (nephrolithiasis) was a focus: “Kidney stone formers should eat diets enriched with foods high in calcium and potassium in order to prevent those painful recurrent kidney stones.”
Another disease erupting from crystal deposition is gout. Uric acid precipitates in the joints, and sometimes the kidney, too.
Gout, which now affects more than 12 million US adults, is an independent risk factor for nephrolithiasis. Recent reports claim that Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) can help with both.
Keep reading with a 7-day free trial
Subscribe to BioMedWorks’ Newsletter to keep reading this post and get 7 days of free access to the full post archives.